Cancer Survivorship Improvements in cancer screening, early detection, and treatment are
resulting in increased numbers of patients cured of cancer. These persons face a wide …

Pain is a common symptom among patients with cancer. Adequate pain assessment and
management are critical to improve the quality of life and health outcomes in this population …

Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline
on use of integrative therapies during and after breast cancer treatment that was determined …

Purpose Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based
chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which …

Neuropathic cancer pain (NCP) is caused by nerve damage attributable to the cancer per
se, and/or treatments including chemotherapy, radiotherapy, and surgery; the prevalence is …

Abstract The National Cancer Policy Forum of the National Academies of Sciences,
Engineering and Medicine sponsored a workshop on July 24 and 25, 2017 on Long-Term …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting and
disabling side effect of taxane anticancer agents. We prospectively evaluated the efficacy of …

Cancer patients experience symptoms and adverse effects of treatments that may last even
after the end of treatments. Exercise is a safe, non-pharmacological and cost-effective …

Purpose In this multicenter study, we evaluated the cumulative burden of morbidity (CBM)
among> 1,200 testicular cancer survivors and applied factor analysis to determine the co …

Testicular cancer has become the paradigm of adult‐onset cancer survivorship, due to the
young age at diagnosis and 10‐year relative survival of 95%. This clinical review presents …